Surgery Partners (SGRY) Preferred Stock Liabilities (2017 - 2021)

Surgery Partners has reported Preferred Stock Liabilities for 5 years, with the latest figure at $439.7 million in Q1 2021.

• Quarterly Preferred Stock Liabilities rose 8.7% year-over-year to $439.7 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $439.7 million (up 8.7% YoY) and the FY2020 annual result came in at $434.5 million, up 10.0% from the prior year.
• Preferred Stock Liabilities improved to $439.7 million in Q1 2021 per SGRY's latest filing, from $434.5 million in the prior quarter.
• Over five years, Preferred Stock Liabilities peaked at $439.7 million in Q1 2021 and troughed at $310.0 million in Q3 2017.
• A 5-year average of $378.0 million and a median of $376.6 million in 2019 frame the typical range for Preferred Stock Liabilities.
• The sharpest annual moves came in 2018 and 2020: Preferred Stock Liabilities grew 8.62% in 2018, then increased 10.0% in 2020.
• Over 5 years, Preferred Stock Liabilities stood at $330.8 million in 2017, then advanced by 8.62% to $359.3 million in 2018, then climbed by 9.94% to $395.0 million in 2019, then climbed by 10.0% to $434.5 million in 2020, then climbed by 1.2% to $439.7 million in 2021.
• According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $439.7 million, $434.5 million, and $424.2 million for Q1 2021, Q4 2020, and Q3 2020 respectively.